Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53-oriented cancer therapies: current progress.

W M Gallagher1, R Brown

  • 1Oncology Department, Rhône-Poulenc Rorer, CRVA, Vitry-sur-Seine, France.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventable death evaluation of the appropriateness of the on-site trauma care provided by Urgences-Santé physicians.

The Journal of trauma·1995
Same author

Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.

Journal of the National Cancer Institute·1995
Same author

Health education intervention strategies: recommendations for future research.

Health education quarterly·1995
Same author

Immunological detection of Bacteroides fragilis in clinical samples.

Journal of medical microbiology·1995
Same author

Trauma center designation: initial impact on trauma-related mortality.

The Journal of trauma·1995
Same author

The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium.

Anesthesiology·1995

Harnessing knowledge of p53 protein, crucial in cancer, enables new therapies. Strategies include gene replacement, function restoration, and targeting p53 dysfunction for improved cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The p53 protein is a critical cellular responder to stress, particularly DNA damage.
  • Disruption of p53 function is frequent in human cancers and linked to poor prognosis.
  • Understanding p53's role in apoptosis and cell cycle arrest is advancing rapidly.

Purpose of the Study:

  • To review current progress in developing p53-oriented cancer therapies.
  • To highlight strategies for exploiting p53 biology in cancer treatment.
  • To discuss the potential and developmental status of novel p53-based therapies.

Main Methods:

  • Review of current research on p53 biology and cancer.
  • Categorization of p53-oriented cancer therapy strategies.

Related Experiment Videos

  • Analysis of the potential efficacy and specificity of different therapeutic approaches.

    • Main Results:

    • Three main therapeutic strategies identified: gene replacement, function restoration, and targeting p53 dysfunction.
    • Conventional agents acting independently of or preferentially in p53-defective cells are progressing.
    • Gene replacement therapy with wild-type p53 shows promise for rapid clinical results.

    Conclusions:

    • p53-oriented cancer therapies offer significant potential, with varying developmental timelines.
    • Further understanding of p53 biology is key to innovating specific and effective cancer treatments.
    • Targeting p53 dysfunction may offer greater long-term efficacy and specificity.